Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Cerilliant
Moodys
Johnson and Johnson
Chubb
US Army
Deloitte
Fuji
Daiichi Sankyo
Mallinckrodt

Generated: October 23, 2017

DrugPatentWatch Database Preview

Zydus Pharms Usa Company Profile

« Back to Dashboard

What is the competitive landscape for ZYDUS PHARMS USA, and what generic and branded alternatives to ZYDUS PHARMS USA drugs are available?

ZYDUS PHARMS USA has one hundred and forty-one approved drugs.

There are nine tentative approvals on ZYDUS PHARMS USA drugs.

Summary for Applicant: Zydus Pharms Usa

US Patents:0
Tradenames:120
Ingredients:121
NDAs:141
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc
ANASTROZOLE
anastrozole
TABLET;ORAL078921-001Jun 28, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa
LAMOTRIGINE
lamotrigine
TABLET;ORAL077633-005Jan 27, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
POTASSIUM CITRATE
potassium citrate
TABLET, EXTENDED RELEASE;ORAL203546-002Aug 6, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa
ZONISAMIDE
zonisamide
CAPSULE;ORAL077625-001Oct 16, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
LEVETIRACETAM
levetiracetam
TABLET;ORAL078918-002Apr 29, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
DULOXETINE HYDROCHLORIDE
duloxetine hydrochloride
CAPSULE, DELAYED REL PELLETS;ORAL090728-002Jan 8, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
GALANTAMINE HYDROBROMIDE
galantamine hydrobromide
TABLET;ORAL078898-002Feb 17, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
TABLET;ORAL207743-003Sep 19, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
DONEPEZIL HYDROCHLORIDE
donepezil hydrochloride
TABLET;ORAL090100-001Oct 24, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
AMIODARONE HYDROCHLORIDE
amiodarone hydrochloride
TABLET;ORAL079029-001Sep 16, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for ZYDUS PHARMS USA drugs

Drugname Dosage Strength Tradename Submissiondate
omeprazole
Delayed-release Tablets20 mg
OMEPRAZOLE
6/3/2015

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Citi
Daiichi Sankyo
Federal Trade Commission
Covington
Boehringer Ingelheim
Julphar
US Army
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot